Thomas Oxley (@tomoxl) 's Twitter Profile
Thomas Oxley

@tomoxl

Founder & CEO Synchron @synchroninc

ID: 1263311951658053632

linkhttp://tomoxl.com calendar_today21-05-2020 03:33:49

336 Tweet

11,11K Followers

158 Following

Thomas Oxley (@tomoxl) 's Twitter Profile Photo

We are unveiling a roadmap to “Cognitive AI”, in partnership with NVIDIA. The ultimate destination of BCI will be large scale brain foundation models of cognition. Emily Mullin from WIRED has done a great job capturing what that means. Peter Yoo presented our vision in a

We are unveiling a roadmap to “Cognitive AI”, in partnership with <a href="/nvidia/">NVIDIA</a>. The ultimate destination of BCI will be large scale brain foundation models of cognition. <a href="/emilylmullin/">Emily Mullin</a> from <a href="/WIRED/">WIRED</a> has done a great job capturing what that means. <a href="/petereyoo/">Peter Yoo</a> presented our vision in a
Thomas Oxley (@tomoxl) 's Twitter Profile Photo

Humbled by interactions over the last few weeks with brilliant minds working on NeuroAI. We are doing preliminary experimentation work on foundation models of cognition and it is raising a bunch of amazing questions Sean Escola Juan Benet Maryam Shanechi Patrick Mineault

Synchron (@synchroninc) 's Twitter Profile Photo

“Forget the headlines—Neuralink may be louder, but Synchron is further along. It reached FDA trials first, secured a global IP footprint, and partnered with NVIDIA. Boards betting on visibility over defensibility may be backing the wrong horse." "While Neuralink commands

“Forget the headlines—<a href="/neuralink/">Neuralink</a> may be louder, but Synchron is further along. It reached FDA trials first, secured a global IP footprint, and partnered with <a href="/nvidia/">NVIDIA</a>. Boards betting on visibility over defensibility may be backing the wrong horse."

"While Neuralink commands
Thomas Oxley (@tomoxl) 's Twitter Profile Photo

Implantable BCI company? Not for the faint hearted. It’s ~ 15+ years. Control your burn if early. You can’t spend to accelerate safety. (Below, “clinical” means fully implantable technology stack and company sponsored trial) Assumptions based on class 3 PMA stories and looking

Thomas Oxley (@tomoxl) 's Twitter Profile Photo

Australia is world class in top-tier scientific output per capita, but is below average in start up company formation in deep tech / biotech / medtech. Israel is world class in start up company formation, entrepreneurial and innovation culture, despite having lower scientific